Elsevier

Immunology Letters

Volume 30, Issue 2, October 1991, Pages 201-205
Immunology Letters

Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa

https://doi.org/10.1016/0165-2478(91)90026-7Get rights and content

Abstract

Pseudomonas aeruginosa, an extracellular opportunistic pathogen, utilizes two major mechanisms to evade the host defence system. One of these mechanisms is the production of a large number of extracellular products, such as proteases, toxins, and lipases. The two proteases, alkaline protease and elastase, inhibit the function of the cells of the immune system (phagocytes, NK cells, T cells), inactivate several cytokines (IL-1, IL-2, IFN-r, TNF), cleave immunoglobulins and inactivate complement. Inhibition of the local immune response by bacterial proteases provides an environment for the colonization and establishment of chronic infection. The other mechanism by which P. aeruginosa evades the host defence system is the biofilm mode of growth of the bacteria in chronic infections. The biofilm-grown bacteria induce a low phagocyte response, and provide a barrier for the bacteria against antibodies, complement, and the cells of the immune system. Protection from the host defence system combined with increased antibiotic resistance of the bacteria in the biofilm are the major reasons for the persistence of P. aeruginosa in chronic infections.

References (49)

  • G. Döring et al.

    Zentralbl. Bakt. Hyg.

    (1981)
  • N. Nishino et al.

    J. Biol. Chem.

    (1980)
  • N. Høiby et al.

    Acta Pathol. Microbiol. Scand. C.

    (1977)
  • S.A. Carney et al.

    Br. J. Dermatol.

    (1973)
  • D.E. Woods et al.

    Rev. Infect. Dis.

    (1983)
  • A. Kharazmi
  • S.S. Pedersen et al.

    Infect. Immun.

    (1990)
  • R.W. Ruhen et al.

    J. Clin. Pathol.

    (1980)
  • N. Høiby

    Acta Paediatr. Scand.

    (1982)
  • M.J. Parmley et al.

    J. Immunol.

    (1986)
  • M. Berger et al.

    J. Clin. Invest.

    (1989)
  • R.J.J. Cassino et al.

    Pediatr. Res.

    (1980)
  • M.J. Thomassen et al.

    Pediatr. Res.

    (1980)
  • N. Høiby et al.

    Acta Pathol. Microbiol. Scand. B.

    (1973)
  • J.D. Klinger et al.

    J. Infect. Dis.

    (1978)
  • G. Döring et al.

    Infect. Immun.

    (1983)
  • A. Kharazmi et al.

    Eur. J. Clin. Invest.

    (1986)
  • S. Suter et al.

    J. Infect. Dis.

    (1984)
  • M.J. Parmely et al.

    J. Exp. Med.

    (1984)
  • R.B. Markham et al.

    J. Immunol.

    (1985)
  • A. Kharazmi et al.

    Infect. Immun.

    (1984)
  • A. Kharazmi et al.

    Infect. Immun.

    (1984)
  • A. Kharazmi et al.

    Acta Pathol. Microbiol. Immunol. Scand. Sect. C.

    (1986)
  • A. Kharazmi et al.

    Acta Pathol. Microbiol. Immunol. Scand.

    (1991)
  • Cited by (126)

    • Leptospira and leptospirosis

      2023, Molecular Medical Microbiology, Third Edition
    • Mycobacterium tuberculosis modifies cell wall carbohydrates during biofilm growth with a concomitant reduction in complement activation

      2021, The Cell Surface
      Citation Excerpt :

      Deposition of C3b and C1q-binding to the bacterial surface of Streptococcus pneumoniae biofilms is impaired, enabling pneumococcal biofilms to avoid the activation of the classical pathway (Domenech et al., 2013). Pseudomonas aeruginosa growing planktonically resulted in a stronger activation of complement than biofilms (Jensen et al., 1993), which could be inactivating the complement system by secreting alkaline protease and elastase (Kharazmi et al., 1991). Biofilms are likely to have a plethora of wide-reaching interactions and effects on the innate immune response.

    • Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies

      2021, Cell Reports
      Citation Excerpt :

      These chronic infections persist even after initiation of highly effective CFTR modulator therapy (Hisert et al., 2017); thus, a better understanding of how P. aeruginosa eludes killing by both host immune factors and antibiotics remains a critical area of research. Physical disruption of P. aeruginosa aggregates in laboratory experiments can restore susceptibility to killing with antibiotics (Alhede et al., 2011) and cells of the immune system (Jensen et al., 1992; Kharazmi, 1991). Thus, understanding mechanisms that promote cellular aggregation is an important focus of research efforts.

    • Characterization of the role of global regulator FliA in the pathophysiology of Pseudomonas aeruginosa infection

      2018, Research in Microbiology
      Citation Excerpt :

      P. aeruginosa possesses a plethora of virulence factors, including lipopolysaccharides, exopolysaccharides, flagella, pili, pigments, proteases, lipases and exotoxins [21,42]. These molecules enable P. aeruginosa to obtain nutrition, colonize and invade at different locations in the human body, adapt against host defenses and cause damage to the hosts [7,24]. Certain virulence molecules containing the N-terminal signal peptide are secreted by the bacterial type I secretion system (T1SS), the type II secretion system (T2SS) and the type III secretion system (T3SS) [3,16,22].

    View all citing articles on Scopus
    View full text